Treatment of myelodysplastic syndromes in the era of precision medicine and immunomodulatory drugs: a focus on higher-risk disease

Razan Mohty, Rama Al Hamed, Ali Bazarbachi, Eolia Brissot, Arnon Nagler, Amer Zeidan, Mohamad Mohty*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment of myelodysplastic syndromes in the era of precision medicine and immunomodulatory drugs: a focus on higher-risk disease'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry